Publication | Closed Access

Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease

Advanced Kidney DiseaseAngiotensin Receptor–neprilysin InhibitionHypertensionHeart FailureRenal FunctionCardiovascular DiseaseReal-world ExperienceMedicineAntihypertensive TherapyChronic Kidney DiseaseKidney FailureCardiovascular PharmacologyPharmacotherapyRenal PathophysiologyPharmacologyNephrologyAnesthesiology